The value of systolic flow velocity acceleration after PCI Interventional cardiology research can be divided principally into two major methodologies. The first is that of the clinical tabulation of events after an intervention with a new device or clinical method is performed. The second is that of examining and describing the mechanisms of intervention by direct measurements of anatomic, physiological, or biochemical markers obtained in or around the manipulation of a target lesion. Ideally, the mechanisms or markers are coupled to subsequent clinical events, thus producing highly useful and relevant observations, which impact on clinical practice. The European multicentre trials involving interventional coronary physiology have expanded both clinical investigation and interventional mechanism research by dissecting the role of physiologic measurements, namely, pressure or coronary flow velocity (and its components), and the relationship to target lesion behaviour.
The work of the investigators of the Doppler end-point balloon angioplasty trial Europe (Debate I and II) [1, 2] continues in the study by Albertal et al. [3] by further analysing an uncommonly studied variable of coronary flow, systolic velocity acceleration. Measured during Doppler wire pullback through a stenosis as a determinant of a conduit narrowing, flow velocity acceleration, in principle, occurs over a short arterial segment with no intervening branches and reflects lumen narrowing. The conservation of mass principle requires that volume flow is constant despite changing cross-sectional area, and thus the velocity must increase for any smaller cross-sectional area. In addition, in areas of dissection or disruption producing an encroachment into the lumen systolic (and diastolic flow velocity) will be affected by the smaller effective cross-sectional area. Caiati et al. [4] reported previously that coronary flow velocity acceleration of 50% at the stenotic site is highly sensitive (92%) and very specific (100%) for diagnosing an angiographic diameter reduction greater than 50% narrowing. However, obtaining systolic velocity acceleration data requires an additional methodology involving careful withdrawal of the Doppler wire while continuously recording the velocity signals and comparing the velocity change to the reference segment. Like Caiati et al. [4] , Albertal et al. [3] also defined a clinically significant systolic flow velocity acceleration during pullback as a d50% increase in flow from a baseline value obtained from an adjacent reference site within the same target vessel.
In this companion study to one previously published for the Debate I study investigators [5] , Albertal et al. [3] report the value of coronary stenotic flow velocity acceleration in the prediction of longterm angiographic restenosis following balloon angioplasty. Fifty-four patients with systolic velocity acceleration (ASV) were compared to 125 patients without the same finding. The ASV group had a higher restenosis rate (52% vs 30%, P=0·006). ASV was also identified as a strong independent predictor of restenosis by logistical regression with a best cutoff value of 101 cm per second. An accelerated systolic velocity appeared to be sensitive to changes in the treated area and unlike coronary vasodilatory reserve did not depend on the status of the microcirculation or haemodynamics.
It should be no surprise that the addition of physiologic variables to the angiogram provides more detailed information and probably enhances the Editorials 1801 differentiation of clinical outcomes. It should not be necessary to reiterate the limitations of angiography in identifying intraluminal detail within a treated arterial segment. Dissection, luminal irregularity thrombus or partial narrowing or an incomplete result cannot often be revealed by angiography alone, a fact made abundantly clear by intravascular ultrasound and the highly favourable effects of stenting. In fact, restoring a cylindrical arterial lumen improves absolute systolic and diastolic flow, the diastolic/ systolic velocity rates (DSVR) as well coronary flow reserve as a measure of total arterial resistance in the majority of treated patients.
One of the new observations of Albertal et al. [3] in this study is the fact that systolic velocity acceleration was an independent predictor, not related to coronary flow reserve, and thus may be useful when the status of the microcirculation is in question or frankly impaired either before or after an intervention. ASV may thus be an important separator with lesion-specific information for procedural end-points and restenosis prognosis.
Can the ASV replace the trans-stenotic gradient or fractional flow reserve? With regard to resting translesional gradients ( P), ASV by Doppler measurements in the coronary artery, unlike velocity (V) in the aorta, cannot be translated to pressure ( P=4V 2 ) due to the fact that the coefficients of separation and friction are not negligible in small tubes [6] . In addition, fractional flow reserve using hyperemia extends our appreciation of a marginal resting transstenotic resistance, which ASV cannot identify.
The two major drawbacks to this study [3] are mainly practical. The first limitation in using the systolic velocity acceleration is the difficulty of signal acquisition. It could be measured in only 70% of patients. The technical difficulties identifying the systolic velocity signal on pullback might be improved by sophisticated computer analysis during online automatic detection of the raw Doppler signal with off-line post hoc evaluation. Perhaps using both the ASV and the diastolic velocity or the mean velocity would assist in this problem and be as valuable as SV alone.
The second drawback is not truly a limitation but rather a change in interventional practice, that is, simple balloon angioplasty is no longer performed routinely. At the conclusion of the Debate I, II studies and other studies [1, 2, [7] [8] [9] despite excellent results of PTCA, the death of provisional angioplasty was sealed in favour of primary stenting [10] . The controversy regarding whether provisional stenting has a role in current practice has faded with superior outcomes of stenting and will probably disappear altogether with coated stents.
Nonetheless, the interventional cardiology researchers and colleagues of Albertal et al. [3] should be congratulated for enhancing our understanding of lesion morphology and rheology related to restenosis. Despite the fact that stents obviate some of the adverse mechanistic aspects of balloon angioplasty, and that physiology is rarely used in daily practice, anatomic and physiologic data are inextricably linked to outcomes and require our continued exploration to enhance clinical performance.
